CLEVER-1, predominantly expressed on TAMs in GC, is correlated with poor clinical outcomes, and high CLEVER-1+ TAM infiltration is associated with poor or adaptive resistance to PD-1 blockade [320]. This evidence concerns the gene STAB1 and gastric cancer.